MedTrace Logo

Accelerated Partial Breast Irradiation With IMRT in Early Breast Cancer

NCT03583580 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 537

Last updated 2026-05-19

No results posted yet for this study

Summary

This study is to evaluate the efficacy and toxicity of accelerated partial breast irradiation (ABPI) with intensity modulated radiation therapy (IMRT) in low-risk breast cancer treat with breast-conserving surgery.

Conditions

  • Breast Neoplasms
  • Neoplasm Recurrence, Local

Interventions

RADIATION

Accelerated Partial Breast Irradiation

Patients are irradiated to the region of tumour bed using intensity modulated radiation therapy (IMRT)

Sponsors & Collaborators

  • Cancer Institute and Hospital, Chinese Academy of Medical Sciences

    lead OTHER

Principal Investigators

  • Shulian Wang, M.D. · National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
45 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-19
Primary Completion
2030-07-31
Completion
2031-07-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03583580 on ClinicalTrials.gov